Radiation-induced bystander signalling in cancer therapy

由 Prise, Kevin M., O'Sullivan, Joe M.
出版 2009

Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy

由 Nugent, Brenda, Lewis, Sian, O'Sullivan, Joe M
發表在 Cochrane Database Syst Rev (2013)

What is the Role of the Bystander Response in Radionuclide Therapies?

由 Brady, Darren, O’Sullivan, Joe M., Prise, Kevin M.
出版 2013

Opportunities for research in molecular radiotherapy

由 Flux, Glenn D, O'Sullivan, Joe, Gaze, Mark N, Prise, Kevin M
發表在 Br J Radiol (2017)

An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol

由 Ruane-McAteer, Eimear, O’Sullivan, Joe, Porter, Sam, Venderbos, Lionne, Prue, Gillian
發表在 BMC Cancer (2016)

Fiducial marker guided prostate radiotherapy: a review

由 O'Neill, Angela G M, Jain, Suneil, Hounsell, Alan R, O'Sullivan, Joe M
發表在 Br J Radiol (2016)

A study of the biological effects of modulated 6 MV radiation fields

由 Butterworth, Karl T, McGarry, Conor K, O’Sullivan, Joe M, Hounsell, Alan R, Prise, Kevin M
出版 2010

A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy

由 Haseen, Farhana, Murray, Liam J, O'Neill, Roisin F, O'Sullivan, Joe M, Cantwell, Marie M
出版 2010

OUT-OF-FIELD CELL SURVIVAL FOLLOWING EXPOSURE TO INTENSITY-MODULATED RADIATION FIELDS

由 Butterworth, Karl T., McGarry, Conor K., Trainor, Colman, O'Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
出版 2011

Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT)

由 Brown, Malcolm, Murphy, Marie, McDermott, Lauri, McAneney, Helen, O’Sullivan, Joe M., Jain, Suneil, Prue, Gillian
發表在 Pilot Feasibility Stud (2019)

The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.

由 Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., Menamin, Úna C. Mc
發表在 Epidemiology (2020)

DNA Damage Responses following Exposure to Modulated Radiation Fields

由 Trainor, Colman, Butterworth, Karl T., McGarry, Conor K., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Prise, Kevin M.
出版 2012

The mediastinal staging accuracy of 18F-Fluorodeoxyglycose Positron Emission Tomography / Computed Tomography in non-small cell lung cancer with variable time intervals to surgery.

由 Booth, Karen, Hanna, Gerard G, McGonigle, Niall, McManus, Kieran G, McGuigan, James, O’Sullivan, Joe, Lynch, Tom, McAleese, Jonathan
出版 2013

A Kinetic-Based Model of Radiation-Induced Intercellular Signalling

由 McMahon, Stephen J., Butterworth, Karl T., Trainor, Colman, McGarry, Conor K., O’Sullivan, Joe M., Schettino, Giuseppe, Hounsell, Alan R., Prise, Kevin M.
出版 2013

ELEVATION OF C-FLIP IN CASTRATE-RESISTANT PROSTATE CANCER ANTAGONIZES THERAPEUTIC RESPONSE TO ANDROGEN-RECEPTOR TARGETED THERAPY

由 McCourt, Clare, Maxwell, Pamela, Mazzucchelli, Roberta, Montironi, Rodolfo, Scarpelli, Marina, Salto-Tellez, Manuel, O’Sullivan, Joe M., Longley, Daniel B., Waugh, David J.J.
出版 2012

Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy

由 Denis-Bacelar, Ana M, Chittenden, Sarah J, McCready, V Ralph, Divoli, Antigoni, Dearnaley, David P, O’Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
發表在 Br J Radiol (2018)

A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy

由 Lyons, Ciara A., King, Raymond B., Osman, Sarah O.S., McMahon, Stephen J., O’Sullivan, Joe M., Hounsell, Alan R., Jain, Suneil, McGarry, Conor K.
發表在 Radiat Oncol (2017)

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program

由 Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O’Sullivan, Joe M., Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica, Nilsson, Sten, Saad, Fred
發表在 BMC Cancer (2019)

Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis

由 McCourt, Clare M., McArt, Darragh G., Mills, Ken, Catherwood, Mark A., Maxwell, Perry, Waugh, David J., Hamilton, Peter, O'Sullivan, Joe M., Salto-Tellez, Manuel
出版 2013

Phase I/II trials of (186)Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival

由 Denis-Bacelar, Ana M., Chittenden, Sarah J., Dearnaley, David P., Divoli, Antigoni, O’Sullivan, Joe M., McCready, V. Ralph, Johnson, Bernadette, Du, Yong, Flux, Glenn D.
發表在 Eur J Nucl Med Mol Imaging (2016)